Integra Lifesciences Holdings (IART) Annual Balance Sheets

Annual · GAAP · USD millions
Access IART quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Integra Lifesciences Holdings adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent235.05
Short-term Investments, Total28.69
Cash & Short-term Investments263.00
Accounts receivable278.85
Inventories492.74
Other Current Assets28.13
Prepaid Expense, Current AS96.09
Total Current Assets1,159.54
Equipment/Property/Plant Net444.34
Goodwill net615.16
Intangible Assets1,134.66
Other Assets, Noncurrent248.30
Deferred Income Tax Assets Net69.85
Total Assets3,602.00
Liabilities
Accounts Payable, Trade, Current95.73
Accrued Liabilities, Current204.57
Secured Debt, Current LO38.75
Other Liabilities, Current113.28
Taxes Payable, Current, Total3.65
Total Current Liabilities455.98
Long-term debt1,729.56
Secured Debt1,729.56
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt1,729.56
Other liabilities, Noncurrent204.28
Contract With Customer Liability Current11.46
Operating Lease Liability Current14.02
Deferred Income Tax Liabilities Net163.06
Total Liabilities2,558.54
Stockholders' Equity
Treasury Stock Common Value-689.21
Common Stock Value0.92
Treasury Stock Value0.00
Additional Paid In Capital Common Stock1,338.39
Retained Earnings / Accumulated Deficit423.44
Other Equity-30.08
Common Stockholder's Equity1,043.46
Total Stockholder's Equity1,043.46
Liabilities & Stockholder's Equity3,602.00
4 historic quarters locked

Sign in to unlock the full Integra Lifesciences Holdings balance sheet history.

About Integra Lifesciences Holdings Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: iart-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000917520-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.